Kbc Group Nv Pfizer Inc Transaction History

Kbc Group Nv

$32.2 Billion
Q1 2025

A detailed history of Kbc Group Nv transactions in Pfizer Inc stock. As of the latest transaction made, Kbc Group Nv holds 3,501,105 shares of PFE stock, worth $84 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

3,501,105

Previous 3,301,369 6.05%

Holding current value

$84 Million

Previous $87.6 Million 1.29%

% of portfolio

0.28%

Previous 0.24%

46 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$25.01 - $27.13 $5 Million - $5.42 Million	199,736 Added 6.05%	3,501,105 $88.7 Million
Q4 2024 Jan 22, 2025	BUY	$24.8 - $30.19 $4.86 Million - $5.92 Million	195,936 Added 6.31%	3,301,369 $87.6 Million
Q3 2024 Nov 06, 2024	BUY	$27.7 - $31.39 $17.7 Million - $20.1 Million	639,985 Added 25.96%	3,105,433 $89.9 Million
Q2 2024 Jul 17, 2024	SELL	$25.26 - $29.6 $191 Million - $224 Million	-7,577,179 Reduced 75.45%	2,465,448 $69 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $147 Million - $168 Million	5,666,590 Added 129.49%	10,042,627 $279 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $36.7 Million - $47.7 Million	1,405,842 Added 47.33%	4,376,037 $126 Million
Q3 2023 Feb 15, 2024	BUY	$32.09 - $37.51 $4.64 Million - $5.42 Million	144,522 Added 4.84%	3,129,268 $104 Million
Q2 2023 Feb 15, 2024	SELL	$36.12 - $41.79 $41 Million - $47.5 Million	-1,136,220 Reduced 27.57%	2,984,746 $109 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $26.3 Million - $30.4 Million	-727,663 Reduced 19.68%	2,970,195 $109 Million
Q1 2023 Feb 14, 2024	SELL	$39.39 - $51.28 $7.55 Million - $9.83 Million	-191,774 Reduced 4.91%	3,714,770 $152 Million
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $16.2 Million - $21.1 Million	-411,077 Reduced 10.0%	3,697,858 $151 Million
Q4 2022 Feb 14, 2024	SELL	$41.75 - $54.5 $6.54 Million - $8.54 Million	-156,618 Reduced 3.85%	3,906,544 $200 Million
Q3 2022 Feb 15, 2024	SELL	$43.76 - $53.42 $11.2 Million - $13.6 Million	-255,071 Reduced 5.83%	4,120,966 $180 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $3.25 Million - $3.97 Million	74,362 Added 1.84%	4,108,935 $180 Million
Q2 2022 Feb 14, 2024	BUY	$46.53 - $55.17 $31.3 Million - $37.1 Million	671,884 Added 19.81%	4,063,162 $213 Million
Q2 2022 Jul 26, 2022	BUY	$46.53 - $55.17 $29.9 Million - $35.5 Million	643,295 Added 18.97%	4,034,573 $212 Million
Q1 2022 Feb 14, 2024	BUY	$45.75 - $56.69 $27 Million - $33.5 Million	591,086 Added 21.11%	3,391,278 $176 Million
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $27 Million - $33.5 Million	591,086 Added 21.11%	3,391,278 $176 Million
Q4 2021 Feb 14, 2024	SELL	$41.32 - $61.25 $65.1 Million - $96.5 Million	-1,575,845 Reduced 36.01%	2,800,192 $165 Million
Q4 2021 Feb 03, 2022	BUY	$41.32 - $61.25 $31.6 Million - $46.8 Million	764,806 Added 37.58%	2,800,192 $165 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $17.1 Million - $21.9 Million	434,801 Added 27.17%	2,035,386 $87.5 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $9.36 Million - $10.6 Million	260,736 Added 19.46%	1,600,585 $62.7 Million
Q1 2021 Apr 26, 2021	BUY	$33.49 - $37.77 $7.29 Million - $8.22 Million	217,588 Added 19.39%	1,339,849 $48.5 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $4.75 Million - $6.04 Million	-141,818 Reduced 11.22%	1,122,261 $41.3 Million
Q3 2020 Oct 28, 2020	SELL	$31.75 - $37.25 $53.7 Million - $63 Million	-1,691,378 Reduced 57.23%	1,264,079 $46.4 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $2.29 Million - $2.78 Million	-76,041 Reduced 2.51%	2,955,457 $96.6 Million
Q1 2020 May 04, 2020	BUY	$27.03 - $38.62 $13.8 Million - $19.7 Million	509,998 Added 20.23%	3,031,498 $98.9 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $47.4 Million - $53.7 Million	-1,438,535 Reduced 36.33%	2,521,500 $98.8 Million
Q3 2019 Nov 07, 2019	BUY	$32.49 - $42.13 $128 Million - $166 Million	3,951,190 Added 44671.45%	3,960,035 $135 Million
Q2 2019 Dec 03, 2019	SELL	$36.98 - $41.52 $135 Million - $152 Million	-3,655,813 Reduced 99.76%	8,845 $383,000
Q2 2019 Jul 30, 2019	BUY	$36.98 - $41.52 $135 Million - $152 Million	3,655,813 Added 41331.97%	3,664,658 $0
Q1 2019 Dec 03, 2019	SELL	$37.5 - $41.2 $149 Million - $163 Million	-3,961,318 Reduced 99.78%	8,845 $376,000
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $148 Million - $163 Million	3,958,998 Added 35459.01%	3,970,163 $0
Q4 2018 Dec 03, 2019	SELL	$38.47 - $43.86 $149 Million - $170 Million	-3,879,133 Reduced 99.71%	11,165 $487,000
Q4 2018 Jan 31, 2019	BUY	$38.47 - $43.86 $149 Million - $170 Million	3,878,983 Added 34281.78%	3,890,298 $161 Million
Q3 2018 Dec 03, 2019	SELL	$34.47 - $41.81 $134 Million - $163 Million	-3,893,546 Reduced 99.71%	11,315 $499,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $134 Million - $163 Million	3,893,546 Added 34410.48%	3,904,861 $0
Q2 2018 Dec 03, 2019	SELL	$32.98 - $35.16 $113 Million - $120 Million	-3,423,962 Reduced 99.67%	11,315 $411,000
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $113 Million - $120 Million	3,423,962 Added 30260.38%	3,435,277 $0
Q1 2018 Dec 03, 2019	SELL	$31.91 - $37.02 $116 Million - $134 Million	-3,631,498 Reduced 99.69%	11,315 $402,000
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $116 Million - $134 Million	3,631,498 Added 32094.55%	3,642,813 $0
Q4 2017 Dec 03, 2019	SELL	$33.26 - $35.29 $103 Million - $109 Million	-3,083,029 Reduced 99.63%	11,315 $410,000
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $103 Million - $109 Million	3,083,029 Added 27247.27%	3,094,344 $0
Q3 2017 Dec 03, 2019	SELL	$31.0 - $34.15 $102 Million - $112 Million	-3,285,253 Reduced 99.66%	11,315 $404,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $102 Million - $112 Million	3,285,253 Added 29034.49%	3,296,568 $0
Q2 2017 Dec 03, 2019	BUY	N/A	11,315	11,315 $380,000

Others Institutions Holding PFE

# of Institutions

3,370

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $135B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account